Venetoclax induced a complete response in a patient with immunoglobulin light chain amyloidosis plateaued on cyclophosphamide, bortezomib and dexamethasone

被引：48
|
作者：
Leung, Nelson [1 ,2 ]
Thome, Stephan D. [3 ]
Dispenzieri, Angela [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA
[3] Mayo Clin, Div Med Oncol, Rochester, MN USA
来源：
HAEMATOLOGICA | 2018年 / 103卷 / 03期
关键词：
MONOCLONAL GAMMOPATHY; AL AMYLOIDOSIS; THERAPY; TRANSLOCATION; SURVIVAL; T(11/14); MYELOMA;
D O I：
10.3324/haematol.2017.183749
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E135 / E137
页数：3
相关论文
共 50 条
  • [21] Revisiting complete response in light chain amyloidosis
    Sidana, Surbhi
    Dispenzieri, Angela
    Murray, David L.
    Go, Ronald S.
    Buadi, Francis K.
    Lacy, Martha Q.
    Gonsalves, Wilson I.
    Dingli, David
    Warsame, Rahma
    Kourelis, Taxiarchis
    Muchtar, Eli
    Hayman, Suzanne R.
    Kapoor, Prashant
    Kyle, Robert A.
    Leung, Nelson
    Rajkumar, S. Vincent
    Gertz, Morie A.
    Kumar, Shaji K.
    LEUKEMIA, 2020, 34 (05) : 1472 - 1475
  • [22] Rapid Complete Response to Single-Agent Bcl-2 Inhibitor Venetoclax in a Heart-Transplanted Patient with Triple Refractory Immunoglobulin Light-Chain Amyloidosis
    Gran, Charlotte
    Bruchfeld, Johanna Borg
    Ellin, Fredrik
    Nahi, Hareth
    ACTA HAEMATOLOGICA, 2020, 143 (05) : 500 - 503
  • [23] Efficacy and toxicity of bortezomib/dexamethasone chemotherapy in patients with advanced cardiac light chain amyloidosis
    Schoenland, S. O.
    Bochtler, T.
    Kimmich, C.
    Dietrich, S.
    Kristen, A. V.
    Ho, A. D.
    Hegenbart, U.
    ONKOLOGIE, 2012, 35 : 144 - +
  • [24] Quick response to bortezomib plus dexamethasone in a patient with AL amyloidosis in first relapse
    Moscetti, A.
    Saltarelli, F.
    Bianchi, M. P.
    Monarca, B.
    De Biase, L.
    Porrini, R.
    Antolino, G.
    La Verde, G.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2011, 18 : 152 - 154
  • [25] Quick response to bortezomib plus dexamethasone in a patient with AL amyloidosis in first relapse
    Moscetti, A.
    Saltarelli, F.
    Bianchi, M. P.
    Monarca, B.
    De Biase, L.
    Porrini, R.
    Antolino, G.
    La Verde, G.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 205 - 206
  • [26] Cyclophosphamide, bortezomib and dexamethasone (CyBorD): a promising regimen for renal light chain deposit disease
    Dutta, Arunima
    Kesari, Kavitha
    Singh, Trevor
    BMJ CASE REPORTS, 2020, 13 (01)
  • [27] Renal response to treatment in patients with Immunoglobulin Light Chain Amyloidosis
    Cirelli, Delfina
    Elena Wang, Carolina
    Federico Varela, Carlos
    Adela Aguirre, Maria
    Mercedes Nucifora, Elsa
    Barbara Brulc, Erika
    Beatriz Sorroche, Patricia
    Soledad Saez, Maria
    Carretero, Marcelina
    Posadas Martinez, Maria Lourdes
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S38 - S39
  • [28] Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis
    Sidiqi, M. Hasib
    Aljama, Mohammed A.
    Jevremovic, Dragan
    Muchtar, Eli
    Buadi, Francis K.
    Warsame, Rahma
    Lacy, Martha Q.
    Dispenzieri, Angela
    Dingli, David
    Gonsalves, Wilson I.
    Kumar, Shaji
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Leung, Nelson
    Hogan, William J.
    Gertz, Morie A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (11) : 2360 - 2364
  • [29] Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis
    Muchtar, Eli
    Gertz, Morie A.
    LaPlant, Betsy R.
    Buadi, Francis K.
    Leung, Nelson
    O'Brien, Patrick
    Bergsagel, P. Leif
    Fonder, Amie
    Hwa, Yi Lisa
    Hobbs, Miriam
    Helgeson, Dania K.
    Bradt, Erin E.
    Gonsalves, Wilson
    Lacy, Martha Q.
    Kapoor, Prashant
    Siddiqui, Mustaqueem
    Larsen, Jeremy T.
    Warsame, Rahma
    Hayman, Suzanne R.
    Go, Ronald S.
    Dingli, David
    Kourelis, Taxiarchis, V
    Dispenzieri, Angela
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    BLOOD ADVANCES, 2022, 6 (18) : 5429 - 5435
  • [30] A Phase II Trial of Lenalidomide, Cyclophosphamide and Dexamethasone (RCD) in Patients with Light Chain Amyloidosis
    Kumar, Shaji
    Hayman, Suzanne R.
    Buadi, Francis
    Allred, Jacob
    Laumann, Kristina
    Roy, Vivek
    Lacy, Martha Q.
    Gertz, Morie A.
    Detweiler, Kristin
    Birgin, Ann
    Bergsagel, Leif
    Dingli, David
    Mikhael, Joseph R.
    Reeder, Craig B.
    Stewart, Keith
    Zeldenrust, Steven R.
    Rajkumar, Vincent
    Dispenzieri, Angela
    BLOOD, 2009, 114 (22) : 1482 - 1482
12345